about
Liver gene transfer of interkeukin-15 constructs that become part of circulating high density lipoproteins for immunotherapyTherapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myelomaInnate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus.Interleukin-15 in gene therapy of cancer.Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12.Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.Targeting NK-cell checkpoints for cancer immunotherapy.Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes.Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy.In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb.High-density lipoproteins delivering interleukin-15.Immunology and gene therapy: shoulder to shoulder into the fray.Dietary total antioxidant capacity and obesity in children and adolescents.In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer.Dietary fatty acid distribution modifies obesity risk linked to the rs9939609 polymorphism of the fat mass and obesity-associated gene in a Spanish case-control study of children.Lymphatic endothelium forms integrin-engaging 3D structures during DC transit across inflamed lymphatic vessels.Predictor factors for childhood obesity in a Spanish case-control study.Sugar-sweetened carbonated beverage consumption and childhood/adolescent obesity: a case-control study.CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.Proliferating NK cells in response to IL-15 do not upregulate surface B220 in vivo.Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein.[The association between dietary macronutrients intake and obesity among children and adolescents; a case-control study].No evidence of association between the serotonin 2A receptor--1438G/A promoter polymorphism and childhood obesity in a Spanish population: A case-parent study and a matched case-control study.Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.Immunostimulatory Monoclonal Antibodies and Immunomodulation: Harvesting the Crop.TV watching modifies obesity risk linked to the 27Glu polymorphism of the ADRB2 gene in girls.A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population.International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010.Association between obesity and insulin resistance with UCP2–UCP3 gene variants in Spanish children and adolescentsGene–gene interaction between PPARγ2 and ADRβ3 increases obesity risk in children and adolescentsCytokines in clinical cancer immunotherapyRole of PPAR-γ2 polymorphisms in bodyweight regulationThe liver, liver metastasis and liver cancer: a special case for immunotherapy with cytokines and immunostimulatory monoclonal antibodiesProphylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapyImmune Desertic Landscapes in Hepatocellular Carcinoma Shaped by β-Catenin ActivationDaratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
P50
Q34533728-2B9149E4-9579-4A98-8A95-F6A51607FE39Q36975064-EDD6A9EE-1D3F-4C9C-9AF1-3FFB14D58482Q37499424-ACF0DC5C-D8DE-465E-9D0A-FE05B68487F9Q38060229-BFAB58E4-0547-455E-9A67-EAF91ACE7911Q38926780-335B54CA-008D-4E9E-BD6B-0E91437F5428Q39096595-8F768B92-81F2-4797-8CCC-C935598F9474Q39110347-B8EE44F8-3A2F-4128-AACC-C6FC1E6D2206Q39150423-41D59D0E-D4E8-4B78-831C-EC7599FCDD94Q39602916-636B47A8-9DA1-4B6F-AFEC-72AB4FB6D525Q39724400-823453D0-8350-4B29-99FD-190D1DE81BDDQ39815528-1680909C-ED13-4DA4-A750-03E2AD4AA92EQ40724784-17832888-884D-4E8F-A1D9-83F166CC58A2Q42870502-B3090A09-6FC3-4C5A-B4E1-B33739BA229FQ43042754-F3BB6F8B-02C9-455A-B5E1-A250D8F93309Q43290042-2D138274-591F-41DA-B838-38F335AC3CDCQ43709860-191D6995-3E7F-4CC3-9FA9-147CD560686BQ44435170-FC5D32D5-FAC4-47CA-BBDD-23C3588D8AC9Q44861260-CC819141-06D9-4FC3-8D72-50B800483CF7Q45229206-678AA3B7-C82A-4DDD-9CC0-C2A297EE3817Q45881397-98118DDD-6712-4A30-8277-D8F495CE2B0EQ45889304-76F5E0BA-4FC7-4083-AC80-18A8F87B3108Q46748932-097D73C4-75B1-4334-A6BC-FAA68B9F4217Q46943307-BCC4F62F-2FC1-4116-A8D1-DA370FF96AB8Q46955103-DF9F9CC0-4287-4BAD-A6C6-C47B5308462AQ47225780-677A4EB3-E638-4866-937E-44E68BB33A4CQ51700392-451763E5-9219-4A98-B6B5-203A82C22D4DQ51734795-6BD1B3E3-B0E4-4921-9A26-4962E38F431BQ51753742-4529CB84-2E6B-4290-8FCF-1785A296F901Q53157680-5BCA622B-3855-4CD9-A891-EE3A4B0D0821Q58074954-DC5BB700-92D0-4EE0-A3BE-7C01061BC300Q58075052-F0FB5B17-30A6-40C4-A28F-62A63DAA7762Q58561585-2B6EF9AC-60DC-42F9-87DF-75B4A41C8383Q60472301-143C9D07-C0E8-47D2-83BF-CF7296D37683Q62637816-5E5DF226-7115-4C69-AB56-4E2288C4A202Q91676943-257F4704-C89E-4FA0-9045-A08F5EB294CCQ92350709-F7A47198-D361-4EA9-A9DD-982B43A7E9DBQ92385628-FF8A53BF-8680-4D24-B00B-11498FCEC37A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria C. Ochoa
@ast
Maria C. Ochoa
@en
Maria C. Ochoa
@es
Maria C. Ochoa
@nl
Maria C. Ochoa
@sl
type
label
Maria C. Ochoa
@ast
Maria C. Ochoa
@en
Maria C. Ochoa
@es
Maria C. Ochoa
@nl
Maria C. Ochoa
@sl
prefLabel
Maria C. Ochoa
@ast
Maria C. Ochoa
@en
Maria C. Ochoa
@es
Maria C. Ochoa
@nl
Maria C. Ochoa
@sl
P1053
K-4508-2017
P106
P1153
7004916849
P21
P31
P3829
P3835
mentxu-ochoa
P496
0000-0001-9920-2144